Acute myocardial infarction due to the unprotected left main coronary artery disease: The power of TIMI 3 flow
More details
Hide details
Świętokrzyskie Cardiology Center, Kielce, Poland
Silesian Center for Heart Diseases, Zabrze, Poland
Submission date: 2013-12-21
Acceptance date: 2014-07-24
Online publication date: 2014-08-15
Publication date: 2020-04-06
Corresponding author
Marcin Sadowski   

Świętokrzyskie Cardiology Center, Grunwaldzka 45, 25-736 Kielce, Poland. Tel.: +48 41 3671580; fax: +48 41 3671456.
Pol. Ann. Med. 2014;21(2):86-89
Acute myocardial infarction (MI) due to unprotected left main coronary artery (ULMCA) as an infarct-related artery is a rare disease with a poor in-hospital and long-term outcome. A nearly linear correlation between post-percutaneous coronary intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) 3 grade and improved outcome is well known, however poorly reported in regard to ULMCA.

To assess the impact of pre- and post-procedural TIMI flow grade on outcomes of emergency PCI in men and women with acute MI due to the ULMCA disease.

Material and methods:
Data were selected from the ongoing, nationwide, multicenter, prospective, observational registry. The study group consisted of 643 consecutive patients hospitalized during one year with acute MI with ULMCA as an infarct-related artery. Data analyzed included information from patients' history, coronary risk factor profile, clinical presentation, therapeutic approach and adjunctive treatment. The primary end-points were in-hospital, 30-day, and 12-month mortality.

Results and discussion:
There were 184 women and 459 men (28.6% vs. 71.4%), P < 0.0001. PCI was performed in 120 women and in 279 men (65.2% vs. 60.8%; P = 0.3) with a high rate of post-procedural TIMI 3 flow (87.6% vs. 82.1%; P = 0.17). Successful PCI defined as the restoration of TIMI flow grade 3 was the only factor decreasing in-hospital (OR 0.1, 95% CI (0.05–0.23), P < 0.0001) and 12-month (OR 0.2, 95% CI (0.13–0.3), P < 0.0001) mortality.

In patients with acute MI survival after ULMCA PCI depended on TIMI grade before and after the procedure.

None declared.
Montalescot G, Brieger D, Eagle KA, et al. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J. 2009;30:2308–2317.
TIMI Study Group.The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932–936.
Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130.
Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010;31:2501–2505.
King 3rd SB, Smith Jr SC, Hirshfeld Jr JW et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008;51:172–209.
Lee MS, Sillano D, Latib A, et al. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction. Catheter Cardiovasc Interv. 2009;73:15–21.
Lee SW, Hong MK, Lee CW, et al. Early and late clinical outcomes after primary stenting of the unprotected left main coronary artery stenosis in the setting of acute myocardial infarction. Int J Cardiol. 2004;97:73–76.
Tan CH, Hong MK, Lee CW, et al. Percutaneous coronary intervention with stenting of the left main coronary artery with drug-eluting stent in the setting of acute ST elevation myocardial infarction. Int J Cardiol. 2008;126:224–228.
Prasad SB, Whitbourn R, Malaiapan Y, et al. Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis. Catheter Cardiovasc Interv. 2009;73:301–307.
Sadowski M, Gasior M, Gierlotka M, Janion M, Poloński L. Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention. 2011;6:1068–1072.
Poloński L, Gasior M, Gierlotka M, et al. Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol. 2007;65:861–872.
Polish Registry of Acute Coronary Syndromes PL-ACS.
Sadowski M, Gutkowski W, Janion-Sadowska A, et al. Acute myocardial infarction due to left main coronary artery disease: a large multicenter national registry. Cardiol J. 2013;20:190–196.
De Luca G, van't Hof AW, Ottervanger JP, et al. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J. 2005;150:557–562.
De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223–1225.
Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104:636–641.
Parma A, Fiorilli R, De Felice F, et al. Early and mid-term clinical outcome of emergency PCI in patients with STEMI due to unprotected left main coronary artery disease. J Interv Cardiol. 2012;25:215–222.
Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–1296.
Mehta RH, Ou F, Peterson ED, et al. Clinical significance of post-procedural TIMI Flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. J Am Coll Cardiol Intv. 2009;2:56–64.
Pappalardo A, Mamas MA, Imola F, et al. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction. J Am Coll Cardiol Intv. 2011;4:618–626.
Journals System - logo
Scroll to top